Tafamidis is a benzoxazole derivative used as an active pharmaceutical ingredient. It is a monocarboxylic acid and a member of the 1,3-benzoxazoles class, developed for applications related to transthyretin-mediated amyloidosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Vyndamax?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Megestrol acetate
pharmaceutical raw material
Algestone
pharmaceutical raw material
Berberine chloride dihydrate
pharmaceutical raw material
Sodium oxolinate
pharmaceutical raw material
5-Bromo-2-phenyl-1,3-benzoxazole
pharmaceutical intermediate
4-bromo-2-phenylbenzo[d]oxazole
research compound
STK360416
research compound
The international HS code for Vyndamax (CAS 594839-88-0) is 2934.99.
2934.99
2934 99 90
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid
TXEIIPDJKFWEEC-UHFFFAOYSA-N
C1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
Sourcing Vyndamax?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.